Ikarian Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-47,408
Closed -$3.45M 138
2022
Q1
$3.45M Buy
+47,408
New +$3.45M 0.45% 30
2021
Q3
Hold
0
180
2021
Q2
Hold
0
201
2020
Q2
Sell
-184,989
Closed -$2.26M 118
2020
Q1
$2.26M Buy
+184,989
New +$2.26M 0.17% 35